Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?

Antiretroviral drugs are being tried as candidates for the pre-exposure prophylaxis (PrEP) against HIV for a considerable period, due to their potential for immediate inhibition of viral replication. Discrepancies in the findings called for a critical review of the relevant efforts and their outcome...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Artif Cells Nanomed Biotechnol
Asıl Yazarlar: Yu, Wenya, Wang, Lu, Han, Na, Zhang, Xiayan, Mahapatra, Tanmay, Mahapatra, Sanchita, Babu, Giridhara R., Tang, Weiming, Detels, Roger, Zhao, Jinkou
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4312541/
https://ncbi.nlm.nih.gov/pubmed/25078629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/21691401.2014.934458
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller